Company intelligence / Profile preview

Arcis Biotechnology

Daresbury (Sci-Tech Daresbury campus), England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Arcis Biotechnology develops and commercializes rapid nucleic acid sample preparation kits and reagents (including CE‑marked IVD products) that enable DNA/RNA extraction from diverse sample types in under ~3 minutes without conventional purification; these are used as enabling tools for molecular diagnostics, PCR/qPCR/RT‑qPCR, and biothreat detection rather than as therapeutic products.[1][3][9][10][11]

Industry: Molecular Diagnostics

Partnerships

Licensing partners for Arcis sample preparation and preservation technology (OEM integration with sample preparation or assay development manufacturers)[9][10]

Beyond the preview

Go deeper on Arcis Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcis Biotechnology.

Explore the full profile